28 January 2021

Research on stress reveals new cells and drug targets

Research at the Weizmann Institute of Science and Max Planck Institute of Psychiatry, focused on uncovering the activities organs, tissues and cells responsible for our body’s stress response has revealed new cells and possible new drug targets.

Chronic stress is a prevailing condition of our time. In the short term, our jaws or stomachs may clench but in the long term, stress can lead to metabolic disease and speed up diseases of aging, as well as leading to more serious psychological disorders.

The physical manifestations of stress originate in the brain, and they move along a so-called ‘stress axis’ that ends in the adrenal glands. These glands then produce the hormone cortisol. When the stress axis is continually activated, changes occur in the cells and organs along the way, and the continual production of cortisol substantially contributes to chronic stress symptoms.

The stress response axis starts with the hypothalamus in the brain, moves through the pituitary right next to the brain and then on to the adrenal glands near the kidneys. Weizmann scientists in Israel and the Max Planck Institute in Germany used new technology to view the entire stress axis in a way never seen before. Their findings, published in Science Advances may be relevant to a number of stress-related diseases from anxiety and depression to metabolic syndrome and diabetes.

The new study, led by postdoctoral fellow Dr Juan Pablo Lopez in the joint neurobiology lab of Professor Alon Chen at the Weizmann Institute of Science and the Max Planck Institute of Psychiatry, made use of a relatively new technique that allows researchers to identify differences across all cell types in a tissue.

This method is something like identifying the individual fruits in a bowl of fruit salad – rather than the standard methods of turning that fruit salad into a ‘smoothie’ and then trying to identify the average characteristics of all the fruits together. But in this case, the task was much more complex than separating the apples from oranges: Pablo Lopez and the team mapped the entire length of the stress axis, checking the activities of numerous single cells all along the route. And they conducted this analysis on two sets of mice – one unstressed and one exposed to chronic stress.

All in all, the team mapped 21,723 cells along the three points in that axis, and they compared their findings from the two sets of mice. They noted that as the stress message moved from one organ to the next, the gene expression in the cells and the tissues themselves underwent greater changes.

The team found 66 genes that were altered between normal and stressed mice in the hypothalamus, 692 in the pituitaries and a whopping 922 in the adrenals. The adrenals are glands that can change their size visibly under chronic stress exposure, and it was here that the researchers noted the most significant alterations among the various cells.

The unprecedented resolution of the technique enabled the researchers to identify, for the first time, a subpopulation of adrenal cells that may play a crucial role in the stress response and adaptation. These were endocrine cells sitting in the outer layer, or adrenal cortex.

Among other things, the team identified a gene, known as Abcb1b, and found it to be overexpressed in these cells under stress situations. This gene encodes a pump in the cell membrane that expels substances from the cell, and the scientists think it plays a role in the release of cortisol.

“If extra stress hormones are created, the cell needs extra release valves to let those hormones go,” said Pablo Lopez.

Are the findings in mice relevant to humans? In collaboration with researchers in university-based hospitals in the United Kingdom, Germany, Switzerland and the United States, the scientists obtained adrenal glands that had been removed from patients to relieve the symptoms of Cushing’s disease.

Though the disease is the result of a growth on the pituitary, the result can be identical to chronic stress – weight gain and metabolic syndrome, high blood pressure and depression or irritability – so in some cases it is treated by removing the adrenal glands, thereby reducing the patients’ stress hormone load. Indeed, the cells in these patients’ adrenals presented a similar picture to those of the mice in the chronic stress group.

The gene they had identified, Abcb1, was known to the researchers from previous studies into the genetics of depression. It had been found that this gene is polymorphic – or has several variants – and that at least one version is tied to a higher risk for depression.

The group analysed the expression of this variant in blood tests taken from a group of subjects who suffer from depression and who were subjected to temporary stress. They found that certain variants do, indeed, affect the ways the adrenal glands deal with stress signals coming down the axis.

Chronic stress can ultimately affect every part of the body and open the door to numerous health issues. The new study, because it looks at the entire axis, on the one hand, and has mapped it down to the gene expression pattern of its individual cells, on the other, should provide a wealth of new information and insight into the mechanisms behind the stress axis.

“Most research in this field has focused on chronic stress patterns in the brain,” said Professor Chen.

“In addition to presenting a possible new target for treating the diseases that arise from chronic stress, the findings of this study will open new directions for future research.”

  • Professor Alon Chen, President of the Weizmann Institute of Science

Recent blog posts

view all +

12 November 2021 | Weizmann in Israel

Weizmann Institute of Science bestows honourary PhDs

The Weizmann Institute of Science bestowed honorary PhDs upon seven individuals on Monday, 8 November, in recognition of their career and personal achievements, in a ceremony broadcast as part of...

read more +

12 November 2021 | Weizmann in Israel

THE WEIZMANN INSTITUTE OF SCIENCE RECEIVES $50 MILLION (USD) FROM THE AZRIELI FOUNDATION TO HELP HUMANITY UNLOCK THE MYSTERIES OF THE BRAIN

The Weizmann Institute of Science recently announced a lead philanthropic donation of $US50 million from the Azrieli Foundation, to enable catalytic brain research with the establishment of The Azrieli Institute...

read more +

9 November 2021 | Weizmann in Israel

The Weizmann Institute of Science Ranked Eighth in the World for Scientific Performance

The Weizmann Institute of Science maintains its status as one of the world’s top research institutions and was recently ranked eighth globally for research quality in a weighted (proportional) ranking published...

read more +